A novel packing arrangement of AcrB in the lipid bilayer membrane  by Ly, K. et al.
FEBS Letters 588 (2014) 4776–4783journal homepage: www.FEBSLetters .orgA novel packing arrangement of AcrB in the lipid bilayer membranehttp://dx.doi.org/10.1016/j.febslet.2014.11.010
0014-5793/ 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
⇑ Corresponding author. Fax: +64 9 923 7414.
1 Current address: Free University of Bozen-Bolzano, piazza Università 5, 39100
Bolzano, Italy.K. Ly a, J.D. Bartho a,1, T. Eicher b, K.M. Pos b, A.K. Mitra a,⇑
a School of Biological Sciences, Private Bag 92019, University of Auckland, Auckland, New Zealand
b Institute of Biochemistry, Max-von-Laue-Str. 9, Goethe-University Frankfurt am Main, Germany1a r t i c l e i n f o
Article history:
Received 24 August 2014
Revised 20 October 2014
Accepted 5 November 2014
Available online 15 November 2014
Edited by Peter Brzezinski
Keywords:
AcrB
Multi-drug efﬂux
2-D crystal
Electron crystallographya b s t r a c t
The central component AcrB of the Escherichia coli drug efﬂux complex AcrA–AcrB–TolC has been
extensively investigated by X-ray crystallography of detergent–protein 3-D crystals. In these crystals,
AcrB packs as trimers – the functional unit. We visualized the AcrB–AcrB interaction in its native
environment by examining E. coli lipid reconstituted 2-D crystals, which were overwhelmingly
formed by asymmetric trimers stabilized by strongly-interacting monomers from adjacent trimers.
Most interestingly, we observed lattices formed by an arrangement of AcrB monomers distinct from
that in traditional trimers. This hitherto unobserved packing, might play a role in the biogenesis of
trimeric AcrB.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The emergence of multidrug resistance of common pathogens
stemming from the widespread and inappropriate use of antibiot-
ics represents an increasing problem in the treatment of infectious
diseases [1]. Strategies commonly used by resistant microbes
include: modiﬁcation of a target enzyme so that it is no longer rec-
ognized by an antibiotic, expression of an antibiotic-degrading
enzyme gene, downregulation of porin gene expression or alter-
ation of the structure of the lipid membrane/receptor proteins so
that the antibiotic cannot enter the cell, or active pumping of the
antibiotic out of the cell [2,3]. The last mechanism is often involved
in multidrug resistant microbes, especially in Gram-negative bac-
teria, and involves membrane transporter systems grouped into
several membrane protein classes: the ABC (ATP-binding cassette)
transporter, the MFS (major facilitator superfamily), the SMR
(small multidrug resistance) family, the RND (resistance nodula-
tion and cell division) transporters, and the MATE (multi antimi-
crobial extrusion) family [4–6]. Clinical isolates of multidrug
resistant Gram-negative pathogens often overproduce these mem-
brane proteins whereby chemical agents noxious to the bacteria
are actively exported from the cell so they cannot reach a lethal
concentration in the bacterial cytoplasm or periplasm.Among these efﬂux systems, the tripartite AcrA–AcrB–TolC
from E. coli is by far the best characterized. The complex is consti-
tutively expressed and provides intrinsic resistance to Escherichia
coli against a wide range of antibiotics, detergent, and dyes [7,8].
AcrA is a periplasmic membrane fusion protein anchored to the
inner membrane through a palmitoyl moiety at residue cysteine
25 [9,10]. The crystal structure of a recombinant AcrA variant resis-
tant to tryptic digestion (lacking 44 residues at the N-terminus and
85 residues at the C-terminus) and various homologs like MexA
and CusB have been reported which indicate a large degree of con-
formational ﬂexibility in the molecule [11]. AcrB is a member of
RND family and is the determinant for substrate speciﬁcity and
energy transduction within the tripartite complex. Several X-ray
crystal structures of asymmetric apo-AcrB or of those with com-
pounds bound to AcrB have been solved [12–17]. TolC is a multi-
functional outer membrane channel and its X-ray structure has
also been solved [18–20]. Although the crystal structures of the
individual components have been solved, the entire assembly has
been proven to be recalcitrant to crystallization. Recently, a tripar-
tite structure deduced from single particle analysis (SPA) of a fused
AcrAZB–TolC structure [21] indicated a stoichiometry of 3:6:3,
conﬁrming the stoichiometries deduced from surface plasmon res-
onance [22] and structures of bipartite homologous systems [23].
For the trimeric inner membrane component AcrB, each subunit
adopts a slightly different conformation (designated L, T and O)
during substrate access, binding and extrusion, respectively
[13,14,24]. Drug transport is driven by the electrochemical proton
gradient across the plasma membrane.
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graphic data, AcrB exhibits a homotrimeric arrangement [12,13,
14,25,26]. As with many other membrane proteins, native lipids
are co-puriﬁed during the AcrB puriﬁcation. Strong indications for
the presence of lipids are available from the 1.9 Å resolution elec-
tron density maps [17], Laser-Induced liquid Bead Ion-Desorption
(LILBID) mass spectrometry and thin layer chromatography [25].
One of the major bottlenecks during the structural analysis by
X-ray crystallography is the co-crystallization of AcrB in complex
with drug substrates. Even though AcrB transports a wide variety
of drugs, dyes, detergents and organic solvents, the asymmetric
trimeric AcrB has been reported to co-crystallize with a limited
set of drugs comprising minocycline, doxorubicin, erythromycin,
rifampicin or dodecyl-maltoside bound to the L or T monomer.
One of the anticipated reasons for the difﬁculties encountered dur-
ing the co-crystallization trials with other drug molecules might be
the presence of a high concentration of the detergent and AcrB sub-
strate (dodecyl-maltoside) present in each setup. In order to study
the AcrB structure in its detergent free state, we carried out 2D crys-
tallization of AcrB in E. coli lipids designed to reveal organization in
the membrane bilayer mimicking the native state. We anticipated
that AcrB would form trimers as revealed uniformly in all reported
3D crystallization studies. In our experiments, AcrB displayed poly-
morphic quaternary organization and packed in overwhelmingly
orthogonal lattices. In these lattices, we observed asymmetric
trimers and in addition non-trimeric arrangements. The ﬁnding of
such non-trimeric AcrB packing is surprising given that AcrB has
been considered to display obligate trimers. The result suggests
that the oligomeric organization and therefore interaction between
AcrB monomers in the lipid bilayer is more varied than in the
detergent-surrounded environment.
2. Results
2.1. AcrBHis puriﬁcation from membrane yields oligomers in solution
AcrBHis was overproduced in E. coli C43 (DE3) growing in LB
medium at 18 C and was extracted from cell membranes using
DDM, CYMAL-6 or Triton-X100. Protein was obtained at high purity
by use of HiTrap Ni2+-Chelating column (GE) (Fig. 1). A small degree
of aggregationwas evident from size exclusion chromatography but
the majority of the protein eluted as a nearly symmetrical peak ofFig. 1. Puriﬁcation of AcrB. Left panel: SDS–PAGE analysis of AcrBHis puriﬁed by Ni2+-afﬁ
(Precision Plus from Bio-rad); T: total cell lysate (2 lg applied); F: ﬂow through; W: was
at 200 mM imidazole, pH 7.0, 100 mM NaCl, 10% glycerol, 0.05% DDM (5 lg applied). Rig
with 10 mM Tris–Cl, pH 7.0, 150 mM NaCl, 5% glycerol, 0.05% DDM, running at 0.5
crystallization.400 kDa corresponding to a trimer of AcrB (approximately
340 kDa plus DDMdetergentmicelle (Fig. 1)). Peak fractions (eluted
at 11–13 mL)were used for subsequent crystallization experiments.
2.2. Reconstitution of AcrB as ordered arrays in lipid bilayers
2.2.1. Effects of detergents and salt on crystal formation
Various detergents were tested for their ability to promote 2-D
crystal formation. It was found that AcrBHis extracted and/or puri-
ﬁed in CYMAL-6 or DDM yielded crystals. Initially, CYMAL-6 used
at a ﬁnal concentration of 0.1% yielded small crystals in the
presence of E. coli polar lipids. Under these conditions, crystal-
containing small vesicles were observed by increasing the concen-
tration of CYMAL-6 (to 0.5%) and also resulted in some tubular
crystals (Fig. S1B). CYMAL-6 concentrations above 1% caused AcrB
aggregation; possibly due to the denaturing effect of this detergent
from prolonged incubation (Fig. S1C). When DDM was used to
purify AcrB, and as a sole detergent in the crystallization mix at a
ﬁnal concentration of 0.1%, small crystalline vesicles were also
observed. However, concentration above 0.25% resulted in mostly
aggregation.
2.2.2. Effects of additives, pH, dialysis temperature and cations on
crystallization
We found that crystals did not form in the presence of EDTA and
that the addition of MgCl2 from 5 to 20 mM yielded crystals consis-
tently, suggesting that divalent cations were important for crystal
formation. In our hand, crystals were only observed with E. coli
polar lipids in a panel of screening experiments that included other
lipids, namely, DMPC, POPC, DLPC or egg PC and PG. Screening
experiments at pH 6.2 or pH 8.0 with appropriate dialysis buffer
did not yield crystals. Most well-ordered crystals were obtained
when dialysis was carried out at 28 C. Reasonably good crystals
were also seen at 25 C and occasionally at 37 C. At 4 C or
18 C, no crystals were formed. Using another detergent (Octyl
Glucoside, Octyl POE, Octyl Maltoside, CYMAL-4, HEGA-10,
MEGA-10, LDAO, FC-12, FC-14, CHAPS at concentrations of
0.1–1.5% depending on the CMC value) as an additive to either
CYMAL-6 or DDM crystallization mix failed to improve crystal
formation. However, addition of DHPC (ﬁnal concentration of
0.25–0.5%) as an additive to the crystallization cocktail (containing
either CYMAL-6 or DDM) uniformly resulted in the generation of anity chromatography (5 mL HiTrap Chelating column). M: molecular mass standard
h with 50 mM imidazole, pH 7.0, 100 mM NaCl, 10% glycerol, 0.05% DDM; E: elution
ht panel: size exclusion chromatogram proﬁle of AcrBHis (Superdex 200 equilibrated
mL/min). Arrow indicates the fractions (eluted at 11–13 mL) being pooled for
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(Fig. S2). In rare cases, very large crystalline sheets were formed
that measured about 4  7 lm (Fig. S3). Addition of Triton-X100
at 0.1–0.25% in crystallization mixture containing DDM yielded
crystals with predominantly hexagonal lattice (Fig. S4); but, the
number of crystalline vesicles were relatively sparse. In our hands,
the cocktail containing CYMAL-6/DHPC or DDM/DHPC in E. coli
polar lipid, 100 mM NaCl, 10 mM MgCl2, potassium phosphate
pH 7.0 with dialysis at 28 C served to reproducibly produce 2-D
crystals.
2.2.3. Packing of AcrB in the E. coli polar lipid membrane
In every reconstitution experiment the majority of 2-D crystals
were the wide, tubular crystals mentioned above. These crystals,
upon ﬂattening on the carbon support ﬁlm overlaying the EM grid
displayed the two lattices for the near and far surfaces (away from
the carbon ﬁlm) that invariably overlapped or were too close to be
reliably separated. This presumably occurs because the AcrB mole-
cules integrated with their large periplasmic face inside causes ste-
ric hinderance and allows for only a small rotation angle between
the two lattices resulting in severe lattice overlap. Fig. 2a shows a
low-dose image of one such crystal wherein the two lattices
(orthogonal; a = 168 Å, b = 182 Å) (Fig. 2b) could be distinguished
(out of more than 100 examined). The extent of overlap is detailed
in Fig. 2c wherein spots belonging to the two lattices are indicated.
Given the predominance of such tubular crystals, attempts were
made to convert these to sheets using a mild detergent (CHAPS, at
below CMC) post crystallization. However, the sheets so produced
were usually disordered and very small (Fig. S4).
As a minor population, a variety of relatively smaller-sized crys-
talline sheets accompanied the aforementioned tubular crystals
and harbored visibly different packing arrangements of AcrB. Like
in the tubular crystals, these sheets were overwhelmingly charac-
terized by orthogonal lattices. Sheets harboring the more tradi-
tional hexagonally packed AcrB trimers were also present; but
these comprised a distinctly minor population. In all, 3 different
orthogonal packing (named type A (a = b = 168 Å) (Fig. 3); type B
(a = 168 Å, b = 182 Å) (Fig. 4) and type C (a = 101 Å, b = 156 Å)
(Fig. 5)) and the hexagonal packing (named type D (a = b = 105 Å)
(Fig. 6)) were identiﬁed and analyzed. The lattice in Type B is iden-
tical to that seen in the major tubular crystals. As deduced using
the program ALLSPACE (see statistics in Supplemental Table 1),
the acceptable plane group of symmetry deﬁning type A lattice is
p22121or p21, this is p22121 for images showing type B lattices,
while it is p1 or p2 for those showing type C lattices. Since cell
edges a and b were nominally identical for type A, p22121 symme-
try was imposed in the reconstructions. The hexagonal type D
lattice conformed to p3 or p312 symmetry.
As can be seen in Figs. 3 and 4, the stabilizing interaction
characterizing the major orthogonal lattices are those betweenFig. 2. 2-D crystal of AcrB. (Left) Section of a micrograph of a tubular 2-D crystal visualiz
of the crystal displaying the two overlapping lattices before application of corrections fo
Fourier transform with the spots belonging to the two lattices designated by square andmonomers belonging to two adjacent asymmetric AcrB trimers
elaborated as strong bands and represent the most noticeable fea-
ture. The type C packing arrangement presents the most interest-
ing observation, which shows bands of doublets of density peaks.
Based on the size of these density peaks, we interpret such crystals
to be formed by a non-trimeric association of AcrB monomers that
has not been reported previously.
Given the novelty of type C lattice, we wanted to conﬁrm that
the generated results were not due to possible stain-induced arte-
facts. For this purpose, we examined crystals embedded in glucose
using a reconstituted sample that contained a large population of
such crystals, as visualized by negative staining. The projection
maps calculated from images of such glucose-preserved specimens
is shown in Fig. 7. Overall, the packing arrangement agrees with
that shown in Fig. 5 with the connection between the two bands
of density more clearly visualized. The reconstructions from indi-
vidual images showing this type C packing (Figs. 5 and 7) varied
somewhat; however, the overall features were consistent.
3. Discussion
AcrB is a very well-studied membrane protein for which a large
number of X-ray crystallographic analyses have been reported. The
3-D crystals in such analyses are composed of largely, lipid-
depleted AcrB surrounded by detergent micelle. In this study, we
investigated the packing arrangement of AcrB in native-like lipid
bilayer membrane, by electron crystallography of AcrB reconsti-
tuted into E. coli polar lipid bilayer membranes. We ﬁnd that in
the 2-D crystals so generated, the predominant lattices are orthog-
onal formed by either asymmetric trimers or non-trimeric associa-
tion of AcrB monomers. Hexagonal lattices of AcrB are also seen
with the traditional symmetric AcrB trimers; but, under our recon-
stitution experiments, these were uniformly a minor population.
Glover et al. [27] have described 2-D crystallization of AcrB in
synthetic lipid bilayer membranes under a variety of lipid and buf-
fer conditions. They observed different packing arrangements of
AcrB, but all barring one out of the 8 observed, namely packing
scheme VII (orthogonal lattice a = b = 231 Å), uniformly comprised
of symmetric AcrB trimers in hexagonal lattices of differing dimen-
sions. The reconstruction of their packing scheme VII shows some
resemblance to that shown in Figs. 5 or 7 for our type C-bands of
density oriented approximately parallel to one of the cell edges
and a distance of 50 Å separating the two prominent peaks in
the density band. Our observed lattice has signiﬁcantly different
dimension (a = 101 Å, b = 156 Å); but more pointedly, Glover
et al. interpret the density in their orthogonal lattice again to be
due to an AcrB trimer as opposed to the non-trimeric association
of monomers described by us.
AcrB puriﬁed in detergent CYMAL-6 and DDM migrate in size
exclusion chromatography with a molecular mass correspondinged by uranyl acetate staining. (Middle) The computed Fourier transform of a section
r lattice distortion. The encircled spot is at 27.7 Å resolution. (Right) The computed
circular boxes.
Fig. 3. Orthogonal crystalline sheet of AcrB (type A). Image (left) of a negatively-stained 2-D crystal and the reconstruction (middle) with p22121 (phase residual = 22.1)
symmetry imposed. One unit cell (a = b = 168 Å) and the asymmetric trimeric unit is indicated. The continuous contours represent stain-excluding protein while the dashed
contours represent regions permeated by stain (as also in Figs. 4–6). Also indicated are the symmetry elements and their locations. Bar = 0.1 lm. The computed Fourier
transform (right) for the image shown (left) before application of corrections for lattice distortion. The encircled spot is at 33.1 Å resolution. The digitized images shown in
this and Figs. 5–7 are 2048  2048 pixels representing a 0.49  0.49 micron area on the specimen.
Fig. 4. Orthogonal crystalline sheet of AcrB (type B). Image (left) of a 2-D crystal of AcrB and the reconstruction (middle) with p22121 symmetry (phase residual = 26.1)
imposed. One unit cell (a = 168 Å, b = 182 Å) and the asymmetric trimeric unit is indicated. Also indicated are the symmetry elements and their locations. Bar = 0.1 lm. The
computed Fourier transform (right) for the image shown before application of correction for lattice distortions. The encircled spot is at 27.6 Å resolution.
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transmission electron microscopy (data not shown, [27,28]). This
peak upon careful examination shows slight asymmetry that could
suggest the presence of another oligomeric state. Brandstätter et al.
[25] showed that under low laser intensity, part of the AcrB sample
was dimeric and Stroebel et al. [29] even postulated a distribution
consisting of several oligomeric species. The question arises as to
the genesis of the novel, non-trimeric arrangement that we
observe in the membrane. It is possible that such a packing
arrangement is an outcome of the dominance of monomer–
monomer interactions across adjacent trimers (Figs. 3–5) that we
observe in our crystals. Thus, the transition from trimeric to non-
trimeric state may not be energy-expensive exploiting another
set of favorable packing interactions that are yet to be revealed.
As mentioned above, we observed crystals with the type C packing
in the same preparation that also had crystals with type A, B and D
packing comprised of trimers. This lends credence to the notion
that this novel form is a bonaﬁde and accessible packing arrange-
ment for AcrB in E. coli lipid bilayer and could be present in vivo as
well.
In order to further understand the non-trimeric packing, we
inquired as to the number and arrangement of AcrB monomers
that could explain the experimentally observed density proﬁle.
For this purpose, we ﬁrst calculated the projected density map
down the 3-fold axis of the X-ray crystal structure of AcrB mono-
mer, representing a view perpendicular to the membrane plane.
Based on visual docking, a plausible arrangement of AcrB mono-
mers to explain the density proﬁle shown in Fig. 7 is indicated in
Fig. 8. In this model there are in all six monomers in the unit cell,three each in the two bands of density with apparent, intimate
monomer–monomer contacts. In such an arrangement, we esti-
mate the number of lipid molecules to be 12 per monomer in
each membrane leaﬂet. This calculation was on the basis of AcrB
monomer to be approximately cylindrical in the membrane with
an elliptical cross section (52  45 Å), membrane thickness of
50 Å and cross-sectional area of 65 Å2 for a phospholipid mole-
cule [30]. This estimated lipid/protein ratio compares reasonably
well with a value of 7–15 observed typically in 2-D crystals of inte-
gral membrane proteins [31].
From current structural and biochemical data [13,14,21,22,
32,33] it has been shown that AcrB assembles inside the AcrAB–TolC
complex as a trimer and exhibits cooperative transport kinetics dur-
ing drug efﬂux. Moreover, artiﬁcially generated AcrB monomers
[25,26] were largely devoid of any functional activity (residual
activity might be due to minor trimer formation). Therefore a tri-
meric assembly appears to be necessary for function. Formation of
alternate, non-trimeric association however, might play a role as
an intermediate in the biosynthesis of trimeric AcrB in the inner
membrane of E. coli. Our observation of the variety of packing
schemes could reﬂect the plasticity of AcrB monomer–monomer
interactions. Therefore it is conceivable that the apposed, string of
3 monomers as seen in type C packing organize to assume the func-
tional trimeric conﬁguration by ﬂexing around the monomer–
monomer interfaces. During biogenesis, single AcrB monomers
have to be assembled into trimers. For instance, dimers formed by
such intimately interactingmonomers could acts as an intermediate
stabilizing species, as dimerization of the AcrA membrane fusion
protein appears to be an assembly intermediate necessary for the
Fig. 5. Orthogonal crystalline sheet of AcrB (type C). Representative images of negatively-stained 2-D crystals (top) and the reconstructed projection maps (middle) with no
imposed symmetry. One unit cell (a = 101 Å, b = 156 Å) is indicated. Bar = 0.1 lm. The computed Fourier transforms (bottom) are for the corresponding images shown before
application of correction for lattice distortions. The encircled spots are at 30.0 and 32.5 Å resolution.
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reveal the molecular surface characterizing the protein interface
in the novel, packing arrangement. For this purpose, one needs to
pursue analysis of the full 3-D structure by recording and analyzing
electron crystallographic data from tilted, unstained type C 2D
crystals.
4. Materials and methods
4.1. Protein expression and puriﬁcation
E. coli strain C43 (DE3) carrying the plasmid pET24 containing
the full length acrB gene including a coding region for a C-terminal6 histidine-tag was used to produce the His-tagged recombinant
protein for puriﬁcation [34] (Supplementary Method).
4.2. Two dimensional crystallization in the lipid bilayer
Puriﬁed protein (ﬁnal concentration of 0.5–1 mg ml1) was
mixed with a variety of lipids at different lipid-to-protein ratio
(1:1 to 1:5) with other ingredients in the crystallization cocktail.
These components included but were not limited to lipids, deter-
gents, salt, buffer and additives. Lipids stocks were stored in chlo-
roform/methanol mixture at 20 C and were dried under N2 gas
before being resuspended at 5 mg ml1 in either water or deter-
gents. The crystallization cocktail (50 lL) was incubated at room
Fig. 6. Hexagonal crystalline sheet of AcrB (type D). Image of negatively-stained 2-D crystal (left) and the reconstruction (middle) with p3 symmetry (phase residual = 8.7)
imposed. One unit cell (a = b = 105 Å) is indicated. Also indicated are the symmetry elements and their locations. Bar = 0.1 lm. The computed Fourier transform (right), before
application of corrections for lattice distortions, shows the two overlapping lattices. The encircled spot is at 30.1 Å resolution. The adjacent trimers (circumscribed) in the
reconstruction, generated from the more ordered of the two lattices, have slightly different stain-excluding density proﬁles. This distinction suggests two oppositely oriented
trimers. The smaller trimer is attributed to that with its cytoplasmic side distal (in contact with the carbon ﬁlm), whereas the larger trimer with interconnected monomer
density is attributed to that with its periplasmic face distal.
Fig. 7. Reconstruction of images of Type C crystals embedded in glucose. (Top) Reconstructions (nominal resolution of 12 Å) generated from 2 different images. The
continuous contours represent protein. One unit cell (a = 101 Å and b = 156 Å) is indicated. No symmetry was imposed. (Bottom) The corresponding plots of the computed
Fourier transforms after lattice unbending, The circles are at 36, 24, 18 and 12 Å resolution in the left panel and in addition at 7 Å resolution in the right panel. The quality of
the spots are signiﬁed by the IQ numbers inside the square boxes.
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mini magnetic stirrer and was then centrifuged (25000g,
30 min, 4 C). The supernatant was transferred to a home-made
mini dialysis chamber fashioned from a 0.5 mL safe-lock centrifuge
tube. A pre-cut dialysis membrane (12–14 kDa MWCO, CelluSep)
pre-treated according to the manufacturer’s speciﬁcation was laid
on top of the lid and then sealed to form the mini dialysis button.
The crystallization cocktail was dialysed against 1000 volume of
buffer (20 mM potassium phosphate pH 7.0, 100 mM NaCl, 10 mM
MgCl2, 0.025% NaN3) under gentle stirring at 28 C usually for10 days with change of dialysis buffer every day. After the comple-
tion of dialysis, samples were recovered from the buttons and
stored at 4 C.
4.3. Electron microscopy
4.3.1. Negative staining
Typically 5 lL of dialysed sample was placed on a plastic sup-
ported carbon coated copper grid which was made hydrophilic
by glow discharging for 20 s. The sample was allowed to settle
Fig. 8. A model for the packing of AcrB in glucose-embedded type C crystals. A 12 Å-ﬁltered projected density map (rendered in gray scale) of the X-ray crystal structure of
AcrB monomer (PDB ID 4DX5) viewed perpendicular to the membrane is used to explain the observed density in the unit cell. The locations and azimuthal orientations of the
3 monomers that can be accommodated in each density band are arrived at visually.
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ﬁltered H2O (50 lL each). The excess water was wicked away
with a piece of ﬁlter paper (Whatman) and the adsorbed sample
was stained for 1 min with 5 lL of 1–2% uranyl acetate solution.
The stain was then wicked away with another piece of ﬁlter paper
and the grid was air-dried.
4.3.2. Glucose embedding
Glucose embedding used the procedure of Chiu et al. [35] with
glucose instead of trehalose in the range of 1–2% concentration and
variable blot times.
4.3.3. Image processing
Initial screening to check for the appearance of 2-D crystals in a
reconstitution experiment was performed using a Philips CM12
microscope equipped with a GATAN BioScan camera and operated
at 120 kV. Low dose Images with an electron dose rate of
20–30 e/Å2/sec at a nominal defocus of 1 to 2 lm were recorded
on Kodak SO-163 ﬁlm using a FEI Tecnai 12 microscope operated
at 120 kV and a nominal magniﬁcation of 42, 000. Images that
showed minimal drift and astigmatism and displayed sharp
diffraction spots in an optical diffractometer were digitized using
a Nikon super coolscan 9000 scanner with a raster step of 10 lm.
Image processing was carried out using either the MRC suite of
software [36] or 2dx [37]. Typically 2048  2048 pixel areas of
the image was selected either manually using Ximdisp [36] or by
using BOXER [38]. Lattices were assigned after picking a minimum
of 10 diffraction spots, and the CTF was assigned manually based
on the positions of the Thon rings. Crystal lattice distortions were
corrected by two rounds of lattice unbending. When using 2dx,
image parameters were calculated using the ‘‘Evaluate Image’’
and ‘‘Determine Spacegroup’’ scripts. Maps were generated follow-
ing the ‘‘Standard Scrips’’ work ﬂow using calculated unit cell
parameters, and initially with no imposed symmetry. Resolution
cut-offs for calculating the projection maps were set as those
beyond which the details in the map did not change noticeably.
4.4. Calculation of projection map for AcrB monomer using X-ray
structure
In order to calculate a simulated projection density map of a
AcrB monomer viewed perpendicular to the membrane plane,
the 3-fold symmetry axis of PDB ID 4DX5 (chain A,B,C) was aligned
with the z axis of a given coordinate system. One monomer was
extracted and its density map computed at a resolution of 12 Åusing the molmap module of UCSF Chimera [39]. This map was
then projected along the z direction using SPIDER [40].
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